Natasha N Pettit

22PUBLICATIONS
23CO-AUTHORS
Medical infection agents (incl. prions)Clinical microbiologyPreventative health careMajor global burdens of diseaseIntensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Dec 04, 2025
Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update.

Michael Klompas, Majdi Al-Hasan, Mayar Al Mohajer

|Nov 27, 2025
An outpatient antimicrobial stewardship needs assessment.

Emma Office, Elizabeth Bell, Natasha N Pettit

|Mar 03, 2025
Curbing inappropriate C. difficile treatment in patients receiving concomitant laxatives.

Paige Fields, Christopher David, Anish Choksi

|Oct 04, 2024
Fidaxomicin versus oral vancomycin for Clostridioides difficile infection among patients at high risk for recurrence based on real-world experience.

Natasha N Pettit, Alison K Lew, Cynthia T Nguyen

|Jul 08, 2024
A Multicenter Retrospective Study Evaluating Intravenous to Oral Antibiotic Stepdown for Uncomplicated Streptococcal Bacteremia.

Alison K Lew, Madison E Salam, Alan E Gross

|Feb 28, 2024
When is vancomycin prophylaxis necessary? Risk factors for MRSA surgical site infection.

Cynthia T Nguyen, Rachel Baccile, Amanda M Brown

Pageof 4